These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Editing the Epigenome: Overview, Open Questions, and Directions of Future Development. Rots MG; Jeltsch A Methods Mol Biol; 2018; 1767():3-18. PubMed ID: 29524127 [TBL] [Abstract][Full Text] [Related]
3. Editing the Epigenome to Tackle Brain Disorders. Liu XS; Jaenisch R Trends Neurosci; 2019 Dec; 42(12):861-870. PubMed ID: 31706628 [TBL] [Abstract][Full Text] [Related]
4. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing. Waryah CB; Moses C; Arooj M; Blancafort P Methods Mol Biol; 2018; 1767():19-63. PubMed ID: 29524128 [TBL] [Abstract][Full Text] [Related]
5. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells. Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202 [TBL] [Abstract][Full Text] [Related]
6. Epigenome editing for targeted DNA (de)methylation: a new perspective in modulating gene expression. Seem K; Kaur S; Kumar S; Mohapatra T Crit Rev Biochem Mol Biol; 2024; 59(1-2):69-98. PubMed ID: 38440883 [TBL] [Abstract][Full Text] [Related]
7. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing. Goubert D; Koncz M; Kiss A; Rots MG Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148 [TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity. Tadić V; Josipović G; Zoldoš V; Vojta A Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448 [TBL] [Abstract][Full Text] [Related]
9. Editing the Epigenome: Reshaping the Genomic Landscape. Holtzman L; Gersbach CA Annu Rev Genomics Hum Genet; 2018 Aug; 19():43-71. PubMed ID: 29852072 [TBL] [Abstract][Full Text] [Related]
10. Regulation of Gene Expression and the Elucidative Role of CRISPR-Based Epigenetic Modifiers and CRISPR-Induced Chromosome Conformational Changes. Martella A; Fisher DI CRISPR J; 2021 Feb; 4(1):43-57. PubMed ID: 33616442 [TBL] [Abstract][Full Text] [Related]
11. CRISPR/dCas-mediated transcriptional and epigenetic regulation in plants. Pan C; Sretenovic S; Qi Y Curr Opin Plant Biol; 2021 Apr; 60():101980. PubMed ID: 33401227 [TBL] [Abstract][Full Text] [Related]
12. A review on CRISPR/Cas-based epigenetic regulation in plants. Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300 [TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas mediated epigenome editing for cancer therapy. Ansari I; Chaturvedi A; Chitkara D; Singh S Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620 [TBL] [Abstract][Full Text] [Related]
14. Investigating crosstalk between H3K27 acetylation and H3K4 trimethylation in CRISPR/dCas-based epigenome editing and gene activation. Zhao W; Xu Y; Wang Y; Gao D; King J; Xu Y; Liang FS Sci Rep; 2021 Aug; 11(1):15912. PubMed ID: 34354157 [TBL] [Abstract][Full Text] [Related]
16. CRISPR-based reagents to study the influence of the epigenome on gene expression. Lavender P; Kelly A; Hendy E; McErlean P Clin Exp Immunol; 2018 Oct; 194(1):9-16. PubMed ID: 30030848 [TBL] [Abstract][Full Text] [Related]
17. A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology. Xu X; Qi LS J Mol Biol; 2019 Jan; 431(1):34-47. PubMed ID: 29958882 [TBL] [Abstract][Full Text] [Related]
18. Development of Locus-Directed Editing of the Epigenome from Basic Mechanistic Engineering to First Clinical Applications. Rots MG; Jeltsch A Methods Mol Biol; 2024; 2842():3-20. PubMed ID: 39012588 [TBL] [Abstract][Full Text] [Related]